 | • レポートコード：MRC2012A7227 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ポリオワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ポリオワクチンの種類別市場規模（IPV、OPV）、用途別市場規模（研究所＆学術研究所、製薬＆バイオテクノロジー産業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Bio-Med、Serum Institute、GSK、Panacea Biotec Ltd、Bibcol、IMBCA、Tiantan Biological、Halfkin Bio-Pharmaceuticals、 ・地域別グローバル市場分析 2015年-2020年 ・ポリオワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ポリオワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ポリオワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ポリオワクチンの南米市場（ブラジル、アルゼンチン） ・ポリオワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：IPV、OPV ・用途別分析：研究所＆学術研究所、製薬＆バイオテクノロジー産業、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Poliomyelitis Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Poliomyelitis Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Poliomyelitis Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Poliomyelitis Vaccines market has been segmented into
IPV
OPV
By Application, Poliomyelitis Vaccines has been segmented into:
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Poliomyelitis Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Poliomyelitis Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Poliomyelitis Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Poliomyelitis Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Poliomyelitis Vaccines Market Share Analysis
Poliomyelitis Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Poliomyelitis Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Poliomyelitis Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Poliomyelitis Vaccines are:
Sanofi
Bio-Med
Serum Institute
GSK
Panacea Biotec Ltd
Bibcol
IMBCA
Tiantan Biological
Halfkin Bio-Pharmaceuticals
Among other players domestic and global, Poliomyelitis Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Poliomyelitis Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Poliomyelitis Vaccines, with price, sales, revenue and global market share of Poliomyelitis Vaccines in 2018 and 2019.
Chapter 3, the Poliomyelitis Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliomyelitis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Poliomyelitis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Poliomyelitis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Poliomyelitis Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Poliomyelitis Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 IPV
1.2.3 OPV
1.3 Market Analysis by Application
1.3.1 Overview: Global Poliomyelitis Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Overview of Global Poliomyelitis Vaccines Market
1.4.1 Global Poliomyelitis Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Med
2.2.1 Bio-Med Details
2.2.2 Bio-Med Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bio-Med SWOT Analysis
2.2.4 Bio-Med Product and Services
2.2.5 Bio-Med Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Serum Institute
2.3.1 Serum Institute Details
2.3.2 Serum Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Serum Institute SWOT Analysis
2.3.4 Serum Institute Product and Services
2.3.5 Serum Institute Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Panacea Biotec Ltd
2.5.1 Panacea Biotec Ltd Details
2.5.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Panacea Biotec Ltd SWOT Analysis
2.5.4 Panacea Biotec Ltd Product and Services
2.5.5 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bibcol
2.6.1 Bibcol Details
2.6.2 Bibcol Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bibcol SWOT Analysis
2.6.4 Bibcol Product and Services
2.6.5 Bibcol Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 IMBCA
2.7.1 IMBCA Details
2.7.2 IMBCA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 IMBCA SWOT Analysis
2.7.4 IMBCA Product and Services
2.7.5 IMBCA Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Tiantan Biological
2.8.1 Tiantan Biological Details
2.8.2 Tiantan Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Tiantan Biological SWOT Analysis
2.8.4 Tiantan Biological Product and Services
2.8.5 Tiantan Biological Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Halfkin Bio-Pharmaceuticals SWOT Analysis
2.9.4 Halfkin Bio-Pharmaceuticals Product and Services
2.9.5 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Poliomyelitis Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Poliomyelitis Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Poliomyelitis Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Poliomyelitis Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Poliomyelitis Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Poliomyelitis Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Poliomyelitis Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Poliomyelitis Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Poliomyelitis Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Poliomyelitis Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Poliomyelitis Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Poliomyelitis Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Poliomyelitis Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
6.4 France Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Poliomyelitis Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Poliomyelitis Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Poliomyelitis Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
7.5 India Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Poliomyelitis Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Poliomyelitis Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Poliomyelitis Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Poliomyelitis Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Poliomyelitis Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Poliomyelitis Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Poliomyelitis Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Poliomyelitis Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Poliomyelitis Vaccines Price by Type (2015-2020)
11 Global Poliomyelitis Vaccines Market Segment by Application
11.1 Global Poliomyelitis Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Poliomyelitis Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Poliomyelitis Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Poliomyelitis Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Poliomyelitis Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Poliomyelitis Vaccines Market Forecast (2021-2025)
12.2.2 Europe Poliomyelitis Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Poliomyelitis Vaccines Market Forecast (2021-2025)
12.2.4 South America Poliomyelitis Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Poliomyelitis Vaccines Market Forecast (2021-2025)
12.3 Poliomyelitis Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Poliomyelitis Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Poliomyelitis Vaccines Market Share Forecast by Type (2021-2025)
12.4 Poliomyelitis Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Poliomyelitis Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Poliomyelitis Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Poliomyelitis Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Poliomyelitis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Poliomyelitis Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Poliomyelitis Vaccines Major Business
Table 9. Sanofi Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Poliomyelitis Vaccines Product and Services
Table 12. Sanofi Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 14. Bio-Med Poliomyelitis Vaccines Major Business
Table 15. Bio-Med Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. Bio-Med SWOT Analysis
Table 17. Bio-Med Poliomyelitis Vaccines Product and Services
Table 18. Bio-Med Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute Poliomyelitis Vaccines Major Business
Table 21. Serum Institute Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. Serum Institute SWOT Analysis
Table 23. Serum Institute Poliomyelitis Vaccines Product and Services
Table 24. Serum Institute Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GSK Basic Information, Manufacturing Base and Competitors
Table 26. GSK Poliomyelitis Vaccines Major Business
Table 27. GSK Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. GSK SWOT Analysis
Table 29. GSK Poliomyelitis Vaccines Product and Services
Table 30. GSK Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Panacea Biotec Ltd Poliomyelitis Vaccines Major Business
Table 33. Panacea Biotec Ltd Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. Panacea Biotec Ltd SWOT Analysis
Table 35. Panacea Biotec Ltd Poliomyelitis Vaccines Product and Services
Table 36. Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bibcol Basic Information, Manufacturing Base and Competitors
Table 38. Bibcol Poliomyelitis Vaccines Major Business
Table 39. Bibcol Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 40. Bibcol SWOT Analysis
Table 41. Bibcol Poliomyelitis Vaccines Product and Services
Table 42. Bibcol Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. IMBCA Basic Information, Manufacturing Base and Competitors
Table 44. IMBCA Poliomyelitis Vaccines Major Business
Table 45. IMBCA Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 46. IMBCA SWOT Analysis
Table 47. IMBCA Poliomyelitis Vaccines Product and Services
Table 48. IMBCA Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 50. Tiantan Biological Poliomyelitis Vaccines Major Business
Table 51. Tiantan Biological Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 52. Tiantan Biological SWOT Analysis
Table 53. Tiantan Biological Poliomyelitis Vaccines Product and Services
Table 54. Tiantan Biological Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Major Business
Table 57. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Total Revenue (USD Million) (2017-2018)
Table 58. Halfkin Bio-Pharmaceuticals SWOT Analysis
Table 59. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product and Services
Table 60. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Poliomyelitis Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Poliomyelitis Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Poliomyelitis Vaccines Sales by Regions (2015-2020) (K Units)
Table 64. Global Poliomyelitis Vaccines Sales Market Share by Regions (2015-2020)
Table 65. Global Poliomyelitis Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Poliomyelitis Vaccines Sales by Countries (2015-2020) (K Units)
Table 67. North America Poliomyelitis Vaccines Sales Market Share by Countries (2015-2020)
Table 68. North America Poliomyelitis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Poliomyelitis Vaccines Revenue Market Share by Countries (2015-2020)
Table 70. Europe Poliomyelitis Vaccines Sales by Countries (2015-2020) (K Units)
Table 71. Europe Poliomyelitis Vaccines Sales Market Share by Countries (2015-2020)
Table 72. Europe Poliomyelitis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Poliomyelitis Vaccines Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Poliomyelitis Vaccines Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Poliomyelitis Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Poliomyelitis Vaccines Sales by Countries (2015-2020) (K Units)
Table 77. South America Poliomyelitis Vaccines Sales Market Share by Countries (2015-2020)
Table 78. South America Poliomyelitis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Poliomyelitis Vaccines Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Poliomyelitis Vaccines Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Poliomyelitis Vaccines Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Poliomyelitis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Poliomyelitis Vaccines Revenue Market Share by Countries (2015-2020)
Table 84. Global Poliomyelitis Vaccines Sales by Type (2015-2020) (K Units)
Table 85. Global Poliomyelitis Vaccines Sales Share by Type (2015-2020)
Table 86. Global Poliomyelitis Vaccines Revenue by Type (2015-2020) (USD Million)
Table 87. Global Poliomyelitis Vaccines Revenue Share by Type (2015-2020)
Table 88. Global Poliomyelitis Vaccines Sales by Application (2015-2020) (K Units)
Table 89. Global Poliomyelitis Vaccines Sales Share by Application (2015-2020)
Table 90. Global Poliomyelitis Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Poliomyelitis Vaccines Market Share Forecast by Regions (2021-2025)
Table 92. Global Poliomyelitis Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Poliomyelitis Vaccines Market Share Forecast by Type (2021-2025)
Table 94. Global Poliomyelitis Vaccines Sales Forecast by Application (2021-2025)
Table 95. Global Poliomyelitis Vaccines Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Poliomyelitis Vaccines Picture
Figure 2. Global Sales Market Share of Poliomyelitis Vaccines by Type in 2019
Figure 3. IPV Picture
Figure 4. OPV Picture
Figure 5. Poliomyelitis Vaccines Sales Market Share by Application in 2018
Figure 6. Research & Academic Laboratories Picture
Figure 7. Pharmaceutical & Biotechnology Companies Picture
Figure 8. Others Picture
Figure 9. Global Poliomyelitis Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Poliomyelitis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Poliomyelitis Vaccines Sales Market Share by Manufacturer in 2019
Figure 30. Global Poliomyelitis Vaccines Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Poliomyelitis Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Poliomyelitis Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Poliomyelitis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Poliomyelitis Vaccines Revenue Market Share by Regions (2015-2020)
Figure 37. Global Poliomyelitis Vaccines Revenue Market Share by Regions in 2018
Figure 38. North America Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
Figure 39. Europe Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
Figure 41. South America Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Poliomyelitis Vaccines Sales and Growth Rate (2015-2020)
Figure 43. North America Poliomyelitis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Poliomyelitis Vaccines Sales Market Share by Countries (2015-2020)
Figure 45. North America Poliomyelitis Vaccines Sales Market Share by Countries in 2018
Figure 46. North America Poliomyelitis Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Poliomyelitis Vaccines Revenue Market Share by Countries in 2018
Figure 48. United States Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Poliomyelitis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Poliomyelitis Vaccines Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Poliomyelitis Vaccines Revenue Market Share by Countries in 2019
Figure 54. Germany Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Poliomyelitis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Poliomyelitis Vaccines Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Poliomyelitis Vaccines Revenue Market Share by Regions 2019
Figure 62. China Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Poliomyelitis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Poliomyelitis Vaccines Sales Market Share by Countries in 2019
Figure 69. South America Poliomyelitis Vaccines Revenue Market Share by Countries in 2019
Figure 70. Brazil Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Poliomyelitis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Poliomyelitis Vaccines Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Poliomyelitis Vaccines Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Poliomyelitis Vaccines Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Poliomyelitis Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Poliomyelitis Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Poliomyelitis Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Poliomyelitis Vaccines Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Poliomyelitis Vaccines Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Poliomyelitis Vaccines Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Poliomyelitis Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Poliomyelitis Vaccines Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
ヒトパピローマウイルス（HPV）ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Papillomavirus (HPV) Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Pap…- デング熱ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 22.8% in the forecast period of 2020 to 2025 and will expected to reach USD 388.8 million by 2025, from USD 171 million in 2019. The Dengue Vaccines market …
- mRNA癌ワクチン・治療薬の世界市場（～2026年） mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…
- ヒトパピローマウイルス（HPV）ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus (HPV) Vaccines Market The global Human Papillomavirus (HPV) Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus (HPV) Vaccines Scope a…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…